Author

R. Allam

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1

Frequent Co-Authors

A. Angelillo-Scherrer· 3 shared N. Andina· 3 shared A. Tardivel· 2 shared C. Ansermet· 2 shared G. Bombaci· 2 shared M. A. Sarangdhar· 2 shared N. Bonadies· 2 shared A. Gazdhar· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

A. Angelillo-Scherrer

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Ribonuclease Inhibitor and Angiogenin collaboratively regulate cell-type-specific global translation

M. Stillinovic, M. A. Sarangdhar, N. Andina, A. Tardivel, F. Greub, G. Bombaci, C. Ansermet, M. Heller, A. Keogh, I. Keller, A. Angelillo-Scherrer, R. Allam

This study identifies RNH1 and ANG as regulators of cell-type-specific global translation, showing RNH1 affects hematopoietic cells while ANG protects non-hematopoietic cells.

bioRxiv · Mar 29, 2024 · PreprintBiochemistry

Heightened NLRP3 inflammasome activation is associated with aging and CMML diseases severity

N. Andina, L. de Meuron, A. S. Schnegg-Kaufmann, C. Ansermet, G. Bomaci, N. Keller, N. A. Porret, A. Angelillo-Scherrer, N. Bonadies, R. Allam

This study shows that aging increases NLRP3 inflammasome sensitivity in monocytes, linking it to inflammation and CMML disease severity.

bioRxiv · Jan 27, 2022 · PreprintImmunology

LRR protein RNH1 dampens the inflammasome activation and is associated with adverse clinical outcomes in COVID-19 patients

G. Bombaci, M. A. Sarangdhar, N. Andina, A. Tardivel, E. C.-W. Yu, G. M. Mackie, M. Pugh, V. B. Ozan, Y. Banz, T. Spinetti, C. Hirzel, E. Youd, J. C. Schefold, G. S. Taylor, A. Gazdhar, , R. Allam

This study identifies RNH1 as an inhibitor of inflammasome activation, showing its protective role in limiting inflammation and its association with worse outcomes in COVID-19.

bioRxiv · Apr 12, 2021 · PreprintImmunology